Kurozumi, Sasagu, Alsaleem, Mansour, Monteiro, Cintia J., Bhardwaj, Kartikeya, Joosten, Stacey E.P., Fujii, Takaaki, Shirabe, Ken, Green, Andrew R., Ellis, Ian O., Rakha, Emad A., Mongan, Nigel P., Heery, David M., Zwart, Wilbert, Oesterreich, Steffi, Johnston, Simon J., "Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets", Breast Cancer Research, 2020